|
|
||||||||
Journal of the American College of Nutrition, Vol 11, Issue 5 532-538, Copyright © 1992 by American College of Nutrition
JOURNAL ARTICLE |
S. Ramasamy, G. A. Boissonneault and B. Hennig
Department of Nutrition and Food Science, University of Kentucky, Lexington 40506-0054.
Cholesterol oxidation products (oxysterols), such as cholestan-3 beta,5 alpha,6 beta-triol (Triol), may be atherogenic by altering the barrier function of the vascular endothelium. We have shown that incubation of endothelial cell monolayers with Triol increased transendothelial albumin transfer (i.e., decreased barrier function) in a concentration- and time-dependent manner. Such dysfunction of endothelium could result from alterations in membrane characteristics, including changes in membrane-associated enzyme activities. To test this hypothesis, endothelial monolayers were treated with 20 microM Triol and the activities of selected membrane enzymes were measured at 0, 2, 4, 6, 12 and 24 hours. Calcium-adenosine triphosphatase (Ca(++)-ATPase) and sodium, potassium, magnesium-adenosine triphosphatase (Na+, K+, Mg(++)-ATPase) activities were significantly increased after 4 or 2 hours incubation with 20 microM Triol, respectively. 5'-nucleotidase activity was significantly elevated only after a 24-hour exposure to Triol, whereas there was no change in angiotensin-converting enzyme (ACE) activity in response to 20 microM Triol treatment at any time studied. Compared with all concentrations tested 40 microM Triol increased Ca(++)-ATPase activity most markedly, with a significant increase already after a 2-hour exposure. No major morphological changes were noted until 12 hours of exposure to 20 microM Triol; obvious cellular damage was observed by 24 hours. Cultures treated with Triol for 24 hours showed significant signs of toxicity, measured by an elevated [3H]adenine release, compared with control cultures. These data demonstrate that Triol alters the activity of certain membrane-bound enzymes, particularly Na+, K+, Mg(++)-ATPase and Ca(++)-ATPase.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
D. W. Seo, H.-S. Choi, S. P. Lee, and R. Kuver Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1247 - G1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Rong, L. Shen, Y. H. Chang, A. Richters, H. N. Hodis, and A. Sevanian Cholesterol Oxidation Products Induce Vascular Foam Cell Lesion Formation in Hypercholesterolemic New Zealand White Rabbits Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2179 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lizard, S. Monier, C. Cordelet, L. Gesquiere, V. Deckert, S. Gueldry, L. Lagrost, and P. Gambert Characterization and Comparison of the Mode of Cell Death, Apoptosis Versus Necrosis, Induced by 7ß-Hydroxycholesterol and 7-Ketocholesterol in the Cells of the Vascular Wall Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1190 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Rong, S. Rangaswamy, L. Shen, R. Dave, Y. H. Chang, H. Peterson, H. N. Hodis, G. M. Chisolm, and A. Sevanian Arterial Injury by Cholesterol Oxidation Products Causes Endothelial Dysfunction and Arterial Wall Cholesterol Accumulation Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1885 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Deckert, A. Brunet, F. Lantoine, G. Lizard, E. M.-v. Brussel, S. Monier, L. Lagrost, M. David-Dufilho, P. Gambert, and M.-A. Devynck Inhibition by Cholesterol Oxides of NO Release From Human Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1054 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, P. Roma, A. Pirillo, F. Pellegatta, and A. L. Catapano Human Endothelial Cells Exposed to Oxidized LDL Express hsp70 Only When Proliferating Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1104 - 1111. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |